Protection against oxidative damage by iron chelators: Effect of lipophilic analogues and prodrugs of N,N'-bis(3,4,5- trimethoxybenzyl)ethylenediamine-N,N'-diacetic acid (OR10141)

Journal of Medicinal Chemistry

Volumn 43, Issue 7, 2000, Pages 1418-1421

  Galey, Jean Baptiste ^a   Destrée, Odile ^a   Dumats, Jacqueline ^a   Génard, Sylvie ^a   Tachon, Pierre ^b  

^a L ORÉAL RECHERCHE   (France)

^b Centre Charles Zviak   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRON CHELATING AGENT; OR 10141;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; IRON CHELATION; MEMBRANE PERMEABILITY; OXIDATIVE STRESS;

ANTIOXIDANTS; CELLS, CULTURED; CYTOPROTECTION; DNA DAMAGE; DNA, SUPERHELICAL; EDETIC ACID; FIBROBLASTS; HUMANS; HYDROGEN PEROXIDE; IRON CHELATING AGENTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRODRUGS; SKIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034611618     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9911635     Document Type: Article

References (20)

1. Voest, E. E.; Vreugdenhil, G.; Marx, J. J. M. Iron chelating agents in non-iron overload conditions. Ann. Intern. Med. 1994, 120, 490-499.
2. Herschko, C.; Pinson, A.; Link, G. Prevention of anthracyeline cardiotoxicity by iron chelation. Acta Haematol. 1996, 95, 87-92.
3. Reddy, B. R.; Kloner, R. A.; Przyklenk, K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Rad. Biol. Med. 1989, 7, 45-52.
4. Gassen, M.; Youdim, M. B. H. The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders. Pharmacol. Toxicol. 1997, 80, 159-166.
5. Pourzand, C.; Watkin, R. D.; Brown, J. E.; Tyrrell, R. M. Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 6751-6756.
6. Reif, D. W. Ferritin as a source of iron for oxidative damage. Free Rad. Biol. Med. 1992, 12, 417-427.
7. Miller, D. M.; Buettner, G. R.; Aust, S. D. Transition metals as catalysts of "autoxidation" reactions. Free Rad. Biol. Med. 1990, 8, 95-108.
8. Hider, R. C.; Singh, S. Iron chelating agents with clinical potential. Proc. R. Soc. Edimb. 1992, 99B (1/2), 137-68.
9. Galey, J.-B. Potential use of iron chelators against oxidative damage. In Advances in Pharmacology, Sies, H., Ed.; Academic Press: New York, 1996; Vol. 38, pp 167-203.
10. Singh, S.; Khodr, H.; Taylor, M. I.; Hider, R. C. Therapeutic iron chelators and their potential side effects. Biochem. Soc. Symp. 1996, 61, 127-137.
11. Porter, J. B.; Huens, E. R. The toxic effects of desferrioxamine. Bailliere's Clin. Haematol. 1989, 2 (2), 459-474.
12. Galey, J.-B.; Dumats, J.; Beck, I.; Fernandez, B.; Hocquaux, M. N,N'-bis Dibenzyl ethylenediaminediacetic acid (DBED): a site specific hydroxyl radical scavenger acting as an "oxidative stress activatable iron chelator" in vitro. Free Rad. Res. 1995, 22, 67-86.
13. 2 catalysed by a μ-oxo diiron (III) complex. Angew. Chem., Int. Ed. Engl. 1996, 35 (20), 2353-2355.
14. 2 activation and aromatic hydroxylation performed by diiron complexes J. Am. Chem. Soc. 1998, 120, 13370-13382.
15. Galey, J.-B.; Destrée, O.; Dumats, J.; Pichaud, P.; Marché, J.; Génard, S.; Bracciolli, G.; LeCapitaine, L.; Plessix, H.; Bramabilla, L.; Cantoni, O. Protection of U937 cells against oxidative injury by a novel series of iron chelators. Free Rad. Biol. Med. 1998, 25 (8), 881-890.
16. Galey, J.-B.; Dumats, J.; Génard, S.; Destrée. O.; Pichaud, P.; Catroux, P.; Marrot, L.; Beck, I.; Fernandez, B.; Barre, G.; Seite, M.; Hussler, G.; Hocquaux, M. N,N′-bis(3,4,5-trimethoxybenzyl) ethylenediamine N,N′-diacetic acid as a new iron chelator with potential medicinal applications against oxidative stress. Biochem. Pharmacol. 1996, 51, 103-115.
17. Pitt, C. G.; Bao, Y.; Thompson, J.; Wani, M. C.; Rosenkrantz, H.; Metterville, J. Esters and lactones of phenolic amino carboxylic acids: prodrugs for iron chelation. J. Med. Chem. 1986, 29, 1231-1237.
18. Sawyer, D. A.; Beams, R. M.; Blackwell, G. J.; Brockwell, M. A.; Cheesman, N. J.; Demaine, D. A.; Garland, L. G.; Hodson, H. F.; Hyde, R. M.; Islip, P. J.; Jackson, W. P.; Parke, A. J.; Rose, V. S.; Smith, S.; Tilling, L.; Wates, P. J. Development of a novel series of trialkoxyaryl derivatives as specific and competitive antagonists of Platelet Activating Factor. J. Med Chem. 1995, 38, 2130-2137.
19. Toyokuni, S.; Sagripanti, J. L. Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron. J. Inorg. Biochem. 1992, 47, 241-248.
20. Tsien, R.; Pozzan, T.; Rink, T. J. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J. Cell Biol. 1982, 94, 325-334.